Share Price and Basic Stock Data
Last Updated: January 29, 2026, 10:57 am
| PEG Ratio | -1.82 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
NOCIL Ltd, a prominent player in the petrochemicals sector, reported a market capitalization of ₹2,164 Cr, with its stock priced at ₹130. The company’s revenue from operations has shown a fluctuating trend, with sales recorded at ₹1,617 Cr for the year ending March 2023. However, the trailing twelve months (TTM) revenue stood at ₹1,315 Cr, indicating a decline in performance compared to the previous fiscal year. Quarterly sales figures reflect this inconsistency, with ₹393 Cr in March 2023, followed by a slight decrease to ₹351 Cr in September 2023. The overall revenue trajectory suggests that NOCIL is experiencing challenges, particularly in maintaining consistent sales growth, which is critical in the competitive petrochemical industry. The operating profit margin (OPM) has also exhibited variability, with the latest OPM reported at 7%, down from higher levels in the past, indicating potential pressures on profitability amidst fluctuating demand and cost dynamics.
Profitability and Efficiency Metrics
NOCIL’s profitability metrics have displayed signs of strain, with a return on equity (ROE) recorded at 5.94% and return on capital employed (ROCE) at 6.65%. These figures fall below the typical sector benchmarks, reflecting challenges in generating shareholder value and efficient capital utilization. The operating profit for the year ending March 2023 was ₹253 Cr, with an operating profit margin of 16%, a decline from previous fiscal highs. The company’s interest coverage ratio (ICR) stood at an impressive 94.70x, indicating robust capacity to cover interest obligations, which is a strength. However, the cash conversion cycle (CCC) stretched to 156 days, suggesting inefficiencies in managing working capital, as longer cycles can lead to liquidity issues. Additionally, net profit for the same period was ₹149 Cr, translating to a net profit margin of 9.22%, which is lower than the prior year’s margin, emphasizing the need for operational efficiencies and cost control measures.
Balance Sheet Strength and Financial Ratios
NOCIL’s balance sheet reflects a conservative borrowing strategy, with total borrowings reported at ₹9 Cr, contributing to a low debt-to-equity ratio. The company’s reserves stood at ₹1,604 Cr, showcasing a strong equity position relative to its liabilities, which amounted to ₹2,057 Cr. The current ratio was reported at 5.82x, indicating excellent short-term liquidity and ability to meet current obligations. However, the price-to-book value ratio (P/BV) of 1.66x suggests that the market values the company at a premium compared to its book value, which could indicate investor expectations of future growth. Furthermore, the company’s asset turnover ratio of 0.68% demonstrates room for improvement in utilizing assets to generate revenue. The financial ratios signal a solid capital structure but also highlight inefficiencies that could be addressed to enhance overall financial health and operational performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of NOCIL reveals a diverse ownership structure, with promoters holding 33.76% of shares, while institutional investors, including foreign institutional investors (FIIs) at 5.16% and domestic institutional investors (DIIs) at 6.57%, represent a smaller portion of ownership. The public holds a significant 54.52%, indicating a broad base of retail investor engagement. Over the past year, the number of shareholders has seen a slight decline from 1,81,692 in December 2022 to 1,64,817 by September 2025, suggesting potential waning interest among retail investors. The gradual increase in FIIs from 5.29% to 8.15% over the same period reflects growing institutional confidence, which is a positive signal. However, the declining public interest could pose risks to share liquidity and stability, necessitating strategies to enhance investor relations and market communication.
Outlook, Risks, and Final Insight
NOCIL faces a mixed outlook characterized by both strengths and challenges. The strong liquidity position and low debt levels provide a solid foundation for navigating economic fluctuations. However, the declining profitability metrics and increasing cash conversion cycle are critical areas of concern that need addressing to enhance operational efficiency. The company’s reliance on a broad public shareholder base may expose it to volatility if investor sentiment shifts. Key risks include potential disruptions in the petrochemical supply chain and fluctuating raw material costs, which could further pressure margins. Strengthening operational efficiencies and enhancing product offerings could mitigate these risks. Overall, while NOCIL has fundamental strengths, strategic actions are necessary to stabilize performance and regain growth momentum in the competitive petrochemical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 33.5 Cr. | 17.1 | 19.6/10.8 | 279 | 41.8 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 35.5 Cr. | 59.5 | 81.5/51.5 | 18.3 | 85.2 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 6.30 Cr. | 15.4 | 34.6/9.89 | 2.07 | 19.5 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 9,623 Cr. | 512 | 982/461 | 35.4 | 118 | 1.95 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 145 Cr. | 49.4 | 81.8/39.0 | 7.14 | 80.3 | 1.00 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 3,019.14 Cr | 142.43 | 50.76 | 83.12 | 1.01% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 389 | 326 | 393 | 397 | 351 | 341 | 356 | 372 | 363 | 318 | 340 | 336 | 321 |
| Expenses | 327 | 288 | 343 | 341 | 306 | 292 | 312 | 331 | 325 | 294 | 305 | 306 | 298 |
| Operating Profit | 62 | 38 | 50 | 56 | 45 | 49 | 45 | 41 | 38 | 24 | 34 | 31 | 22 |
| OPM % | 16% | 12% | 13% | 14% | 13% | 14% | 13% | 11% | 10% | 8% | 10% | 9% | 7% |
| Other Income | 1 | 2 | 3 | 5 | 5 | 6 | 25 | 9 | 8 | 9 | 6 | 7 | 10 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 14 |
| Profit before tax | 49 | 25 | 39 | 47 | 37 | 41 | 56 | 37 | 32 | 19 | 26 | 23 | 19 |
| Tax % | 26% | 26% | 26% | 27% | 26% | 26% | 25% | 26% | -30% | 32% | 20% | 25% | 35% |
| Net Profit | 36 | 19 | 28 | 34 | 27 | 30 | 42 | 27 | 42 | 13 | 21 | 17 | 12 |
| EPS in Rs | 2.14 | 1.12 | 1.70 | 2.06 | 1.63 | 1.80 | 2.49 | 1.62 | 2.52 | 0.77 | 1.24 | 1.03 | 0.73 |
Last Updated: December 29, 2025, 7:05 pm
Below is a detailed analysis of the quarterly data for NOCIL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 321.00 Cr.. The value appears to be declining and may need further review. It has decreased from 336.00 Cr. (Jun 2025) to 321.00 Cr., marking a decrease of 15.00 Cr..
- For Expenses, as of Sep 2025, the value is 298.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 306.00 Cr. (Jun 2025) to 298.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Jun 2025) to 22.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Sep 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Jun 2025) to 7.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Jun 2025) to 10.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 14.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Jun 2025) to 19.00 Cr., marking a decrease of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 35.00%, marking an increase of 10.00%.
- For Net Profit, as of Sep 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.73. The value appears to be declining and may need further review. It has decreased from 1.03 (Jun 2025) to 0.73, marking a decrease of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 596 | 719 | 715 | 742 | 964 | 1,043 | 846 | 925 | 1,571 | 1,617 | 1,445 | 1,393 | 1,315 |
| Expenses | 534 | 605 | 575 | 582 | 695 | 750 | 668 | 793 | 1,284 | 1,364 | 1,250 | 1,255 | 1,203 |
| Operating Profit | 62 | 114 | 140 | 160 | 269 | 293 | 178 | 132 | 288 | 253 | 195 | 137 | 111 |
| OPM % | 10% | 16% | 20% | 22% | 28% | 28% | 21% | 14% | 18% | 16% | 14% | 10% | 8% |
| Other Income | 9 | 3 | 3 | 9 | 11 | 10 | 9 | 14 | 2 | 6 | 39 | 32 | 31 |
| Interest | 17 | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 19 | 14 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 54 |
| Profit before tax | 35 | 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 87 |
| Tax % | 32% | 34% | 34% | 34% | 33% | 33% | 14% | 17% | 27% | 26% | 26% | 10% | |
| Net Profit | 24 | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 63 |
| EPS in Rs | 1.48 | 3.55 | 4.87 | 5.94 | 10.33 | 11.17 | 7.89 | 5.32 | 10.57 | 8.95 | 7.98 | 6.16 | 3.77 |
| Dividend Payout % | 40% | 28% | 25% | 30% | 24% | 22% | 32% | 38% | 28% | 34% | 38% | 32% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 137.50% | 36.84% | 24.36% | 75.26% | 8.82% | -29.19% | -32.82% | 100.00% | -15.34% | -10.74% | -22.56% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.66% | -12.48% | 50.90% | -66.43% | -38.01% | -3.64% | 132.82% | -115.34% | 4.60% | -11.82% |
NOCIL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | -4% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -4% |
| 3 Years: | -16% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 8% |
| 3 Years: | -13% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 11:45 am
Balance Sheet
Last Updated: January 7, 2026, 4:09 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 161 | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 | 167 | 167 |
| Reserves | 217 | 254 | 309 | 750 | 882 | 998 | 1,020 | 1,119 | 1,279 | 1,385 | 1,532 | 1,595 | 1,604 |
| Borrowings | 152 | 147 | 26 | 15 | 5 | 0 | 7 | 6 | 6 | 10 | 13 | 10 | 9 |
| Other Liabilities | 203 | 193 | 186 | 233 | 279 | 279 | 250 | 324 | 380 | 295 | 304 | 284 | 291 |
| Total Liabilities | 732 | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,072 |
| Fixed Assets | 320 | 311 | 307 | 543 | 528 | 657 | 797 | 918 | 909 | 888 | 870 | 855 | 834 |
| CWIP | 3 | 3 | 6 | 4 | 42 | 131 | 156 | 14 | 8 | 9 | 16 | 60 | 176 |
| Investments | 22 | 22 | 22 | 176 | 281 | 130 | 54 | 68 | 53 | 218 | 399 | 366 | 408 |
| Other Assets | 386 | 418 | 347 | 438 | 480 | 524 | 434 | 614 | 859 | 742 | 730 | 776 | 654 |
| Total Assets | 732 | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,072 |
Below is a detailed analysis of the balance sheet data for NOCIL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 167.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 167.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,604.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,595.00 Cr. (Mar 2025) to 1,604.00 Cr., marking an increase of 9.00 Cr..
- For Borrowings, as of Sep 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 291.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 284.00 Cr. (Mar 2025) to 291.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,072.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,057.00 Cr. (Mar 2025) to 2,072.00 Cr., marking an increase of 15.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 834.00 Cr.. The value appears to be declining and may need further review. It has decreased from 855.00 Cr. (Mar 2025) to 834.00 Cr., marking a decrease of 21.00 Cr..
- For CWIP, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 116.00 Cr..
- For Investments, as of Sep 2025, the value is 408.00 Cr.. The value appears strong and on an upward trend. It has increased from 366.00 Cr. (Mar 2025) to 408.00 Cr., marking an increase of 42.00 Cr..
- For Other Assets, as of Sep 2025, the value is 654.00 Cr.. The value appears to be declining and may need further review. It has decreased from 776.00 Cr. (Mar 2025) to 654.00 Cr., marking a decrease of 122.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,072.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,057.00 Cr. (Mar 2025) to 2,072.00 Cr., marking an increase of 15.00 Cr..
Notably, the Reserves (1,604.00 Cr.) exceed the Borrowings (9.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -90.00 | -33.00 | 114.00 | 145.00 | 264.00 | 293.00 | 171.00 | 126.00 | 282.00 | 243.00 | 182.00 | 127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90 | 85 | 77 | 82 | 92 | 81 | 88 | 122 | 104 | 78 | 86 | 81 |
| Inventory Days | 167 | 176 | 135 | 116 | 129 | 133 | 128 | 120 | 141 | 117 | 100 | 129 |
| Days Payable | 122 | 79 | 74 | 82 | 96 | 77 | 84 | 123 | 91 | 52 | 53 | 54 |
| Cash Conversion Cycle | 136 | 182 | 138 | 116 | 125 | 138 | 132 | 119 | 154 | 143 | 133 | 156 |
| Working Capital Days | 57 | 71 | 86 | 86 | 94 | 99 | 104 | 114 | 128 | 108 | 110 | 194 |
| ROCE % | 10% | 19% | 24% | 21% | 26% | 25% | 13% | 9% | 18% | 13% | 10% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Multicap Fund | 1,578,331 | 0.15 | 24.31 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 1,376,260 | 0.32 | 21.2 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 1,100,000 | 0.2 | 16.94 | N/A | N/A | N/A |
| Canara Robeco Manufacturing Fund | 948,605 | 0.92 | 14.61 | 453,736 | 2025-12-08 07:49:24 | 109.07% |
| Canara Robeco Manufacturing Fund | 948,605 | 0.92 | 14.61 | 453,736 | 2025-12-08 07:49:24 | 109.07% |
| Aditya Birla Sun Life Business Cycle Fund | 900,000 | 0.78 | 13.86 | 841,512 | 2025-12-08 01:14:19 | 6.95% |
| ICICI Prudential Commodities Fund | 728,541 | 0.33 | 11.22 | N/A | N/A | N/A |
| Kotak Special Opportunities Fund | 697,703 | 0.66 | 10.75 | N/A | N/A | N/A |
| Mahindra Manulife Manufacturing Fund | 550,000 | 1.14 | 8.47 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 483,825 | 0.45 | 7.45 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.17 | 7.98 | 8.95 | 10.58 | 5.33 |
| Diluted EPS (Rs.) | 6.15 | 7.95 | 8.92 | 10.55 | 5.32 |
| Cash EPS (Rs.) | 9.37 | 11.15 | 12.29 | 13.47 | 7.57 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 105.51 | 101.92 | 93.14 | 86.76 | 77.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 105.51 | 101.92 | 93.14 | 86.76 | 77.29 |
| Revenue From Operations / Share (Rs.) | 83.38 | 86.69 | 97.01 | 94.33 | 55.63 |
| PBDIT / Share (Rs.) | 10.15 | 14.07 | 15.54 | 17.41 | 8.76 |
| PBIT / Share (Rs.) | 6.94 | 10.90 | 12.20 | 14.51 | 6.50 |
| PBT / Share (Rs.) | 6.83 | 10.80 | 12.13 | 14.45 | 6.45 |
| Net Profit / Share (Rs.) | 6.16 | 7.98 | 8.95 | 10.57 | 5.32 |
| NP After MI And SOA / Share (Rs.) | 6.16 | 7.98 | 8.95 | 10.57 | 5.32 |
| PBDIT Margin (%) | 12.17 | 16.22 | 16.01 | 18.45 | 15.73 |
| PBIT Margin (%) | 8.32 | 12.57 | 12.57 | 15.38 | 11.69 |
| PBT Margin (%) | 8.19 | 12.45 | 12.50 | 15.31 | 11.58 |
| Net Profit Margin (%) | 7.38 | 9.20 | 9.22 | 11.20 | 9.56 |
| NP After MI And SOA Margin (%) | 7.38 | 9.20 | 9.22 | 11.20 | 9.56 |
| Return on Networth / Equity (%) | 5.83 | 7.83 | 9.60 | 12.18 | 6.88 |
| Return on Capital Employeed (%) | 6.11 | 9.81 | 12.05 | 15.38 | 7.69 |
| Return On Assets (%) | 5.00 | 6.59 | 8.03 | 9.62 | 5.47 |
| Asset Turnover Ratio (%) | 0.68 | 0.74 | 0.88 | 0.91 | 0.60 |
| Current Ratio (X) | 5.82 | 5.89 | 5.15 | 3.25 | 2.96 |
| Quick Ratio (X) | 4.07 | 4.55 | 3.49 | 1.97 | 2.17 |
| Inventory Turnover Ratio (X) | 5.53 | 5.69 | 2.94 | 3.79 | 3.17 |
| Dividend Payout Ratio (NP) (%) | 48.60 | 37.58 | 33.50 | 18.89 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.96 | 26.90 | 24.40 | 14.82 | 0.00 |
| Earning Retention Ratio (%) | 51.40 | 62.42 | 66.50 | 81.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.04 | 73.10 | 75.60 | 85.18 | 0.00 |
| Interest Coverage Ratio (X) | 94.70 | 144.69 | 215.81 | 266.10 | 150.03 |
| Interest Coverage Ratio (Post Tax) (X) | 58.46 | 83.10 | 125.29 | 162.57 | 92.14 |
| Enterprise Value (Cr.) | 2887.72 | 4059.04 | 3380.38 | 4139.10 | 2821.79 |
| EV / Net Operating Revenue (X) | 2.07 | 2.81 | 2.09 | 2.63 | 3.05 |
| EV / EBITDA (X) | 17.04 | 17.32 | 13.05 | 14.27 | 19.39 |
| MarketCap / Net Operating Revenue (X) | 2.10 | 2.88 | 2.13 | 2.64 | 3.14 |
| Retention Ratios (%) | 51.39 | 62.41 | 66.49 | 81.10 | 0.00 |
| Price / BV (X) | 1.66 | 2.45 | 2.21 | 2.88 | 2.26 |
| Price / Net Operating Revenue (X) | 2.10 | 2.88 | 2.13 | 2.64 | 3.14 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 |
After reviewing the key financial ratios for NOCIL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.17. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.17, marking a decrease of 1.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has decreased from 7.95 (Mar 24) to 6.15, marking a decrease of 1.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.37. This value is within the healthy range. It has decreased from 11.15 (Mar 24) to 9.37, marking a decrease of 1.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 105.51. It has increased from 101.92 (Mar 24) to 105.51, marking an increase of 3.59.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 105.51. It has increased from 101.92 (Mar 24) to 105.51, marking an increase of 3.59.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.38. It has decreased from 86.69 (Mar 24) to 83.38, marking a decrease of 3.31.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10.15. This value is within the healthy range. It has decreased from 14.07 (Mar 24) to 10.15, marking a decrease of 3.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.94. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 6.94, marking a decrease of 3.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.83. This value is within the healthy range. It has decreased from 10.80 (Mar 24) to 6.83, marking a decrease of 3.97.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.16, marking a decrease of 1.82.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.16, marking a decrease of 1.82.
- For PBDIT Margin (%), as of Mar 25, the value is 12.17. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 12.17, marking a decrease of 4.05.
- For PBIT Margin (%), as of Mar 25, the value is 8.32. This value is below the healthy minimum of 10. It has decreased from 12.57 (Mar 24) to 8.32, marking a decrease of 4.25.
- For PBT Margin (%), as of Mar 25, the value is 8.19. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 24) to 8.19, marking a decrease of 4.26.
- For Net Profit Margin (%), as of Mar 25, the value is 7.38. This value is within the healthy range. It has decreased from 9.20 (Mar 24) to 7.38, marking a decrease of 1.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.38. This value is below the healthy minimum of 8. It has decreased from 9.20 (Mar 24) to 7.38, marking a decrease of 1.82.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 15. It has decreased from 7.83 (Mar 24) to 5.83, marking a decrease of 2.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 10. It has decreased from 9.81 (Mar 24) to 6.11, marking a decrease of 3.70.
- For Return On Assets (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 5.00, marking a decrease of 1.59.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.74 (Mar 24) to 0.68, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 5.82. This value exceeds the healthy maximum of 3. It has decreased from 5.89 (Mar 24) to 5.82, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 4.07. This value exceeds the healthy maximum of 2. It has decreased from 4.55 (Mar 24) to 4.07, marking a decrease of 0.48.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.53. This value is within the healthy range. It has decreased from 5.69 (Mar 24) to 5.53, marking a decrease of 0.16.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 48.60. This value is within the healthy range. It has increased from 37.58 (Mar 24) to 48.60, marking an increase of 11.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.96. This value is within the healthy range. It has increased from 26.90 (Mar 24) to 31.96, marking an increase of 5.06.
- For Earning Retention Ratio (%), as of Mar 25, the value is 51.40. This value is within the healthy range. It has decreased from 62.42 (Mar 24) to 51.40, marking a decrease of 11.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.04. This value is within the healthy range. It has decreased from 73.10 (Mar 24) to 68.04, marking a decrease of 5.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 94.70. This value is within the healthy range. It has decreased from 144.69 (Mar 24) to 94.70, marking a decrease of 49.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.46. This value is within the healthy range. It has decreased from 83.10 (Mar 24) to 58.46, marking a decrease of 24.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,887.72. It has decreased from 4,059.04 (Mar 24) to 2,887.72, marking a decrease of 1,171.32.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.07, marking a decrease of 0.74.
- For EV / EBITDA (X), as of Mar 25, the value is 17.04. This value exceeds the healthy maximum of 15. It has decreased from 17.32 (Mar 24) to 17.04, marking a decrease of 0.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 2.10, marking a decrease of 0.78.
- For Retention Ratios (%), as of Mar 25, the value is 51.39. This value is within the healthy range. It has decreased from 62.41 (Mar 24) to 51.39, marking a decrease of 11.02.
- For Price / BV (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.45 (Mar 24) to 1.66, marking a decrease of 0.79.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 2.10, marking a decrease of 0.78.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in NOCIL Ltd:
- Net Profit Margin: 7.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.11% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.83% (Industry Average ROE: 13.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 58.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34 (Industry average Stock P/E: 50.76)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | Mafatlal House, H T Parekh Marg, Mumbai Maharashtra 400020 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Hrishikesh A Mafatlal | Executive Chairman |
| Mr. Anand V S | Managing Director |
| Mr. Priyavrata H Mafatlal | Non Independent Director |
| Mr. Vilas R Gupte | Independent Director |
| Mr. Debnarayan Bhattacharya | Independent Director |
| Mr. A Vellayan | Independent Director |
| Mr. Sujal Shah | Independent Director |
| Mr. Ramesh Iyer | Independent Director |
| Ms. Radhika Haribhakti | Independent Director |
FAQ
What is the intrinsic value of NOCIL Ltd?
NOCIL Ltd's intrinsic value (as of 29 January 2026) is ₹141.52 which is 10.56% higher the current market price of ₹128.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,146 Cr. market cap, FY2025-2026 high/low of ₹240/125, reserves of ₹1,604 Cr, and liabilities of ₹2,072 Cr.
What is the Market Cap of NOCIL Ltd?
The Market Cap of NOCIL Ltd is 2,146 Cr..
What is the current Stock Price of NOCIL Ltd as on 29 January 2026?
The current stock price of NOCIL Ltd as on 29 January 2026 is ₹128.
What is the High / Low of NOCIL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of NOCIL Ltd stocks is ₹240/125.
What is the Stock P/E of NOCIL Ltd?
The Stock P/E of NOCIL Ltd is 34.0.
What is the Book Value of NOCIL Ltd?
The Book Value of NOCIL Ltd is 106.
What is the Dividend Yield of NOCIL Ltd?
The Dividend Yield of NOCIL Ltd is 1.56 %.
What is the ROCE of NOCIL Ltd?
The ROCE of NOCIL Ltd is 6.65 %.
What is the ROE of NOCIL Ltd?
The ROE of NOCIL Ltd is 5.94 %.
What is the Face Value of NOCIL Ltd?
The Face Value of NOCIL Ltd is 10.0.